Testosterone Undecannoate
Hormone Deficiency
Max-Planck-Institute of PsychiatryPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Hormone Deficiency cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Genotropin Max-Planck-Institute of Psychiatry | Phase 2 | CCC |
Gly-Low Hoskinson Health and Wellness Clinic | Early Phase 1 | CC |
AE-PEANUT Al-Balqa Applied University | N/A | D |
LEUPROLIDE Pennington Biomedical Research Center | D |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →